Novel mechanism of ILC2 immune cell development may be involved in exacerbating allergic diseases

byChiba UniversityResearchers identify a G3SE-dependent mechanism of ILC2 development. Credit: Yosuke Toda and Arifumi Iwata from Chiba UniversityOverproduction of Group 2 innate lymphoid cells

Updated on: July 11,2024 0

Novel mechanism of ILC2 immune cell development may be involved in exacerbating allergic diseases

byChiba UniversityResearchers identify a G3SE-dependent mechanism of ILC2 development. Credit: Yosuke Toda and Arifumi Iwata from Chiba UniversityOverproduction of Group 2 innate lymphoid cells

Updated on:July 11,2024 0

Long-term rituximab safe for patients with wegener's

Repeated and prolonged use of rituximab for B-cell depletion to treat relapses or maintain remission is safe and effective in patients with refractory granulomatosis with polyangiitis (GPA; Wegener&#3

Updated on: March 28,2024 17

Long-term rituximab safe for patients with wegener's

Repeated and prolonged use of rituximab for B-cell depletion to treat relapses or maintain remission is safe and effective in patients with refractory granulomatosis with polyangiitis (GPA; Wegener&#3

Updated on:March 28,2024 17

Survival improving after hip and knee replacement

(HealthDay)—Short-term survival after elective total hip (THR) and total knee replacement (TKR) has greatly improved since the early 1990s, even though comorbidities have increased, according to a stu

Updated on: April 08,2024 14

Survival improving after hip and knee replacement

(HealthDay)—Short-term survival after elective total hip (THR) and total knee replacement (TKR) has greatly improved since the early 1990s, even though comorbidities have increased, according to a stu

Updated on:April 08,2024 14

COVID booster vaccines: How a third dose may help vulnerable people 'level up' their immunity

by Nathan Cheetham,The ConversationCredit: Unsplash/CC0 Public DomainCOVID vaccines call our immune systems to action, generating antibodies which fight against any contact we have with the viru

Updated on: April 13,2024 16

COVID booster vaccines: How a third dose may help vulnerable people 'level up' their immunity

by Nathan Cheetham,The ConversationCredit: Unsplash/CC0 Public DomainCOVID vaccines call our immune systems to action, generating antibodies which fight against any contact we have with the viru

Updated on:April 13,2024 16

Study finds antibody-associated vasculitis characteristics and treatments vary across lifespan

by American College of RheumatologyMedications ever received by patients with granulomatosis with polyangiitis and microscopic polyangiitis stratified by age at diagnosis. Credit: The Association

Updated on: May 08,2024 5

Study finds antibody-associated vasculitis characteristics and treatments vary across lifespan

by American College of RheumatologyMedications ever received by patients with granulomatosis with polyangiitis and microscopic polyangiitis stratified by age at diagnosis. Credit: The Association

Updated on:May 08,2024 5

Immune receptor thought to be linked to hearing loss in child cancer survivors confirmed in new study

by Yolanda Poffenroth, Michael Brown,University of AlbertaCredit: Pixabay/CC0 Public DomainPermanent hearing loss triggered by a common chemotherapy drug in half of children being treated for ca

Updated on: May 07,2024 16

Immune receptor thought to be linked to hearing loss in child cancer survivors confirmed in new study

by Yolanda Poffenroth, Michael Brown,University of AlbertaCredit: Pixabay/CC0 Public DomainPermanent hearing loss triggered by a common chemotherapy drug in half of children being treated for ca

Updated on:May 07,2024 16

Visual illusion proves effective in relieving knee pain for people with osteoarthritis

by University of South AustraliaCredit: CC0 Public DomainIn a new study published in the journalPeer Jthis week, researchers at UniSA's Body in Mind Research Group have found peop

Updated on: April 17,2024 13

Visual illusion proves effective in relieving knee pain for people with osteoarthritis

by University of South AustraliaCredit: CC0 Public DomainIn a new study published in the journalPeer Jthis week, researchers at UniSA's Body in Mind Research Group have found peop

Updated on:April 17,2024 13

Increased use of partial knee replacement could save the NHS £30 million per year

by University of OxfordCredit: NDORMSNew research from a randomised clinical trial published today inThe Lancetand funded by the National Institute for Health Research (NIHR) shows th

Updated on: March 28,2024 17

Increased use of partial knee replacement could save the NHS £30 million per year

by University of OxfordCredit: NDORMSNew research from a randomised clinical trial published today inThe Lancetand funded by the National Institute for Health Research (NIHR) shows th

Updated on:March 28,2024 17

Early RA treatment important for long-term outcomes

(HealthDay)—Early treatment of rheumatoid arthritis (RA) is important for long-term outcomes, and there has been a decrease in mortality rates attributable to RA, according to two studies published on

Updated on: March 28,2024 18

Early RA treatment important for long-term outcomes

(HealthDay)—Early treatment of rheumatoid arthritis (RA) is important for long-term outcomes, and there has been a decrease in mortality rates attributable to RA, according to two studies published on

Updated on:March 28,2024 18

T-cells shown to infiltrate brain, cause respiratory distress in condition affecting the immunocompromised

by Liz Ahlberg Touchstone |,University of Illinois at Urbana-ChampaignPulmonary dysfunction and mortality under the C-IRIS condition.ASchematic representation of the experiments and

Updated on: May 05,2024 13

T-cells shown to infiltrate brain, cause respiratory distress in condition affecting the immunocompromised

by Liz Ahlberg Touchstone |,University of Illinois at Urbana-ChampaignPulmonary dysfunction and mortality under the C-IRIS condition.ASchematic representation of the experiments and

Updated on:May 05,2024 13

Declining antibodies and immunity to COVID-19 – why the worry?

by Alexander (Sasha) Poltorak,The ConversationCredit: Pixabay/CC0 Public DomainMost people are aware that testing for antibodies in a person's blood can show if someone has had a specific di

Updated on: April 10,2024 12

Declining antibodies and immunity to COVID-19 – why the worry?

by Alexander (Sasha) Poltorak,The ConversationCredit: Pixabay/CC0 Public DomainMost people are aware that testing for antibodies in a person's blood can show if someone has had a specific di

Updated on:April 10,2024 12

SARS-CoV-2 antibodies detectable up to seven months post COVID-19 onset

by Instituto de Medicina MolecularColorized scanning electron micrograph of a dying cell (blue) heavily infected with SARS-CoV-2 (yellow), the virus that causes COVID-19. Credit: NIAID Integrated Rese

Updated on: April 10,2024 14

SARS-CoV-2 antibodies detectable up to seven months post COVID-19 onset

by Instituto de Medicina MolecularColorized scanning electron micrograph of a dying cell (blue) heavily infected with SARS-CoV-2 (yellow), the virus that causes COVID-19. Credit: NIAID Integrated Rese

Updated on:April 10,2024 14